Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)
Status:
Completed
Trial end date:
2014-09-05
Target enrollment:
Participant gender:
Summary
This study will investigate the safety and tolerability of a flexible dosing regimen of
asenapine for the long-term treatment of manic or mixed episodes associated with bipolar
disorder I in children and adolescents who completed study P06107.